Delivery Order SPE2DB22D1106-SPE2DB25FEVP8
Award Date
6/28/25
Potential Completion Date
6/30/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product BARHEMSYS 10 MG/4 ML VIAL 4ML, with a ceiling value of $3,263.93 and a period of performance through June 11, 2025. The contract is a firm fixed-price delivery order, indicating the agency has a defined requirement and has competitively awarded the order to AmerisourceBergen. As...
This is a firm-fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) to provide BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical drug. The contract has a ceiling value of $1,601.26 and a period of performance through January 29, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $4,579.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product, with a period of performance through January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,215.41, is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a ceiling value of $28,487.26 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BARHEMSYS, a medication used to treat postoperative nausea and vomiting, with a ceiling value of $21,784.03 and a performance period through April 2025. The contract is not set aside and is a firm-fixed-price delivery order, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is for the pharmaceutical product BARHEMSYS 5 MG/2 ML VIAL 2ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.69 firm-fixed-price delivery order has a completion date of September 22, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This contract award is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product, under a Firm Fixed Price delivery order contract valued at $8,138.79. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...